CoreWeave And OpenAI IPOs Will Open New Opportunities

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

04 Apr 25

Updated

08 Dec 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

47.8%

7D

0%

Loading

1Y

47.8%

7D

0%

You can edit this narrative until Dec 9 1:05 PM. Then, changes will post as Updates.

Author's Valuation

US$11.1515.4% undervalued

AnalystConsensusTarget Fair Value

Shared on 08 Dec 25

SSSS: Portfolio Momentum And Buybacks Will Drive Shares Higher

Analysts have raised their price target on SuRo Capital by $1 to $12, citing building momentum across the company's investment portfolio as support for the higher valuation. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the incremental price target increase reflects growing confidence in the durability of portfolio momentum, supporting a premium to prior valuation levels.

Shared on 24 Nov 25

Fair value Increased 1.36%

SSSS: Portfolio Momentum Will Drive Continued Outperformance Following Q3 Report

Analysts have increased their price target for SuRo Capital from $11 to $12, citing recent portfolio momentum as a key factor supporting this modest upgrade. Analyst Commentary Bullish Takeaways Bullish analysts point to SuRo Capital's recent portfolio momentum as a positive driver for valuation, supporting the new price target of $12.

Shared on 07 Nov 25

Fair value Increased 79%

SSSS: Portfolio Momentum And Margin Gains Will Define Next Phase Amid Market Risks

Analysts have raised their price target for SuRo Capital from $6.14 to $11.00. They cite positive portfolio momentum and improved profit margins, despite softer revenue growth.

Shared on 01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

US$11.15

15.4% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

-13.47%

Capital Markets revenue growth rate

0.25%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.89%

Calculation

US$503.33k

Earnings '28

x

858.50x

PE Ratio '28

=

US$432.11m

Market Cap '28

US$432.11m

Market Cap '28

/

30.47m

No. shares '28

=

US$14.18

Share Price '28

US$14.18 Share Price '28

Discounted to 2025 @ 8.91% p.a.

=

US$10.98

Fair Value '25